Lev Pharmaceuticals, Inc. Appoints Vice President, Sales And Marketing; Former OraPharma, Inc. Executive To Build Sales And Marketing Effort Around Hereditary Angioedema
NEW YORK--(BUSINESS WIRE)--Aug. 3, 2006--Lev Pharmaceuticals, Inc. ("Lev" or "the Company") (OTCBB: LEVP), a developer of therapeutics for inflammatory diseases, announced today the appointment of Joseph Truitt to the position of Vice President, Sales and Marketing. Mr. Truitt was previously Vice President, Sales and Operations with OraPharma, Inc., a Johnson & Johnson company.